Literature DB >> 17356115

Mechanical ventilation in ARDS: a state-of-the-art review.

Timothy D Girard1, Gordon R Bernard2.   

Abstract

Mechanical ventilation is an essential component of the care of patients with ARDS, and a large number of randomized controlled clinical trials have now been conducted evaluating the efficacy and safety of various methods of mechanical ventilation for the treatment of ARDS. Low tidal volume ventilation (</= 6 mL/kg predicted body weight) should be utilized in all patients with ARDS as it is the only method of mechanical ventilation that, to date, has been shown to improve survival. High positive end-expiratory pressure, alveolar recruitment maneuvers, and prone positioning may each be useful as rescue therapy in a patient with severe hypoxemia, but these methods of ventilation do not improve survival for the wide population of patients with ARDS. Although not specific to the treatment of ARDS, protocol-driven weaning that utilizes a daily spontaneous breathing trial and ventilation in the semirecumbent position have proven benefits and should be used in the management of ARDS patients.

Entities:  

Mesh:

Year:  2007        PMID: 17356115     DOI: 10.1378/chest.06-1515

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  42 in total

1.  Physical therapy management of ventilated patients with acute respiratory distress syndrome or severe acute lung injury.

Authors:  Frank Chung; Dan Mueller
Journal:  Physiother Can       Date:  2011-04-13       Impact factor: 1.037

2.  The clinical practice guideline for the management of ARDS in Japan.

Authors:  Satoru Hashimoto; Masamitsu Sanui; Moritoki Egi; Shinichiro Ohshimo; Junji Shiotsuka; Ryutaro Seo; Ryoma Tanaka; Yu Tanaka; Yasuhiro Norisue; Yoshiro Hayashi; Eishu Nango
Journal:  J Intensive Care       Date:  2017-07-25

3.  Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?

Authors:  Mark E Mikkelsen; Brian Anderson; Jason D Christie; Ramona O Hopkins; Paul N Lanken
Journal:  Ann Am Thorac Soc       Date:  2014-05

4.  Extracorporeal membrane oxygenation--understanding the evidence: CESAR and beyond.

Authors:  David Sidebotham
Journal:  J Extra Corpor Technol       Date:  2011-03

5.  High Positive End-Expiratory Pressure Is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome.

Authors:  Christian Bime; Mallorie Fiero; Zhenqiang Lu; Eyal Oren; Cristine E Berry; Sairam Parthasarathy; Joe G N Garcia
Journal:  Am J Med       Date:  2016-10-28       Impact factor: 4.965

6.  Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma.

Authors:  Erin L Vanzant; Cecilia M Lopez; Tezcan Ozrazgat-Baslanti; Ricardo Ungaro; Ruth Davis; Alex G Cuenca; Lori F Gentile; Dina C Nacionales; Angela L Cuenca; Azra Bihorac; Christiaan Leeuwenburgh; Jennifer Lanz; Henry V Baker; Bruce McKinley; Lyle L Moldawer; Frederick A Moore; Philip A Efron
Journal:  J Trauma Acute Care Surg       Date:  2014-01       Impact factor: 3.313

Review 7.  Prophylactic protective ventilation: lower tidal volumes for all critically ill patients?

Authors:  Francois Lellouche; Jed Lipes
Journal:  Intensive Care Med       Date:  2012-10-30       Impact factor: 17.440

8.  Effect of ventilation pressure on alveolar fluid clearance and beta-agonist responses in mice.

Authors:  Erin N Z Yu; Zachary P Traylor; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

9.  Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: a case report.

Authors:  Chiara Beretta; Veronica Leoni; Mario Renato Rossi; Momcilo Jankovic; Nicolo Patroniti; Giuseppe Foti; Ettore Biagi
Journal:  J Med Case Rep       Date:  2009-04-01

10.  Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.

Authors:  Rogier M Determann; Julian L Millo; Sam Waddy; Rene Lutter; Chris S Garrard; Marcus J Schultz
Journal:  BMC Pulm Med       Date:  2009-12-03       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.